MDP News & Resources
- Home
- MDP News & Resources
Looking for specific news & resource articles?
Enter a search phrase, select a category or topic, and click the green search button below.
WHO Guide
Lymphatic filariasis elimination programme : training module for drug distributors in countries where lymphatic filariasis is co-endemic with onchocerciasis
Lymphatic filariasis elimination programme: training module – Part 1: Learner’s Guide and Part 2: Tutor’s Guide. WHO Dept. of Communicable Disease Prevention, Control and Eradication.Scientific Publication
Economic evaluation of Mectizan distribution
Article exploring economic impact of Mectizan distribution on affected communities. H. R. Waters, J. A. Rehwinkel, G. Burnham, First published: 13 April 2004.
Waters_et_al-2004-Tropical_Medicine_&_International_Health (90.66 KB)Documents
Recommendations for the treatment of Onchocerciasis with Mectizan® in areas co-endemic for Onchocerciasis and Loiasis
Technical paper. Mectizan Expert Committee and Technical Consulatative Committee, June 2004.
englishmectccloarecs-june04 (42.20 KB)Scientific Publication
Review: The delivery of ivermectin (Mectizan®)
Article addressing the creation of the methods and tools needed to deliver ivermectin and the evolution and development of distribution programmes.
Review The delivery of ivermectin Mectizan (592.94 KB)Scientific Publication
Mectizan Donation Program: evaluation of a public–private partnership
This evaluation examines how the Mectizan Donation Program (MDP) partnership has been functioning from the perspectives of partner organizations. Peters et al, Tropical Medicine and International Health, Volume 9 No 4 pp A4–A15 Suppl, April 2004.
MDP evaluation of a public private partnership (115.99 KB)Scientific Publication
Impact of ivermectin on illness and disability associated with onchocerciasis
Article discussing the impact of ivermectin on onchocerciasis, particularly through Merck & Co., Inc., Kenilworth, N.J., U.S.A.’s * establishment of the Mectizan® Distribution Program (MDP), which was founded to provide a complementary approach to controlling the disabling consequences of this parasitic infection.
Impact of ivermectin on illness and disability associated with onchocerciasis (113.98 KB)Scientific Publication
Eliminating onchocerciasis as a public health problem
Article reviewing the evolution of treatment strategies focused toward the goal of eliminating onchocerciasis as a public health problem. Thylefors, Tropical Medicine and International Health, Volume 9 No 4 pp A1–A3 Suppl, April 2004.
Eliminating onchocerciasis as a public health problem (149.03 KB)WHO Guide
Prévention communautaire à domicile des incapacités dues à la filariose lymphatique
Illustrated instructional guide on caring for symptoms of lymphatic filariasis, French. WHO, 2003.
Scientific Publication
The African Programme for Onchocerciasis Control (APOC) at Mid-point: History, Achievements and Future Challenges
Collection of scientific articles published in the Annals of Tropical Medicine and Parasitology, Volume 96, Supplement 1, 2002.
WHO Guide
Certification of elimination of human onchocerciasis: criteria and procedures
Guidelines. WHO, September 28-29, 2000.Resources and Tools
Preparing and Implementing a National Plan to Eliminate Lymphatic Filariasis: A Guideline for Programme Managers
Preparing and Implementing a National Plan to Eliminate Lymphatic Filariasis (in countries where onchocerciasis is co-endemic): A GUIDELINE FOR PROGRAMME MANAGERS.
Guideline for Programme Managers GAELF (369.69 KB)WHA Resolution
World Health Assembly Resolution: Elimination of lymphatic Filariasis as a Public Health Problem, 1997
WHO World Health Assembly Resolution on Lymphatic Filariasis. WHA 50.29, 1997
WHO World Health Assembly Resolution on Lymphatic Filariasis (12.46 KB)